| Literature DB >> 24984706 |
Silke Fuchs1, Ermelinda Rende2, Andrea Crisanti1, Tony Nolan1.
Abstract
Insecticide resistance amongst disease vectors is a growing problem and novel compounds are needed. Biogenic amines are important for neurotransmission and we have recently shown a potential role for these in mosquito fertility. Here, we dissected the relative contribution of different aminergic signalling pathways to biological processes essential for vectorial capacity such as fertility, locomotion and survival by injecting agonists and antagonists and showed that octopaminergic/tyraminergic signalling is essential for oviposition and hatching rate. We show that egg melanisation is regulated by adrenergic signalling, whose disruption causes premature melanisation specifically through the action of tyramine. In addition to this, co-injection of tyramine with DOPA, the precursor of melanin, had a strong cumulative negative effect on mosquito locomotion and survival. Dopaminergic and serotonergic antagonists such as amitriptyline and citalopram recapitulate this effect. Together these results reveal potential new target sites for the development of future mosquito sterilants and insecticides.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24984706 PMCID: PMC4078307 DOI: 10.1038/srep05526
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Biosynthesis pathway of biogenic amines in invertebrates and vertebrates.
DBH- dopamine β- hydroxylase, DDC- Dopa decarboxylase, PNMT- phenyl ethanolamine-N-methyltransferase, PO- phenoloxidase, TDC- tyrosine decarboxylase, TBH- tyramine beta hydroxylase, TPH- tryptophan hydroxylase. The green and blue squares mark the metabolic reactions specific for either invertebrates or vertebrates respectively. The dotted arrow represents a salvage pathway which might exist12. Its physiological relevance is unknown.
Figure 2Phylogenetic analysis of selected human, fly and mosquito biogenic amine receptors.
Protein sequences of each receptor (“R”) were first aligned in Muscle47 and then a Maximum-Likelihood tree was constructed in MEGA 6 using 1000-fold bootstrap re-sampling. All insect receptors are shown in green, while the human receptors are highlighted in blue. The numbers at the nodes of the branches represent the level of bootstrap support for each branch. The D.melanogaster FMRF amide receptor (DmFR, AAF47700.1) was used as outgroup. The accession numbers for each receptor are listed in Supplementary Table S1.
Adrenergic, dopaminergic and serotonergic action of compounds applied in humans and insects
| compound | function in humans | function in insects | Reference |
|---|---|---|---|
| Tyrosine | Precursor of DOPA, dopamine, adrenaline and noradrenaline | Precursor of DOPA, dopamine, tyramine and octopamine | [ |
| L-DOPA | D(1-4) dopamine receptor agonist, dopamine precursor | Dopamine and DOPA melanin precursor, | [ |
| Dopamine | D(1-4) dopamine receptor agonist, dopamine transport inducer, dopamine beta hydroxylase ligand, | dopamine melanin precursor, Dop1-3 receptor agonist, Oct α2R (OA3) agonist, TyR1 and TyR3 agonist | [ |
| Carbidopa | Aromatic amino acid decarboxylase (AADC) inhibitor | DDC inhibitor | [ |
| Tyramine | Trace amine associated receptor (TAAR) agonist, β-adrenergic receptor 1 and 2 (ADBR1,2) antagonist | Oct α2R (OA3) agonist, TyR1-3 agonist, Dop3 (D2 like) agonist | [ |
| Octopamine | TAAR agonist, ADRB2-antagonist, ADRB1,3-agonist | Oct α2R (OA3) agonist, TyR 1 agonist, OctβR (OA2) agonist, TyR3 agonist | [ |
| Clonidine | α2 adrenergic agonist | TyR > OctR agonist, Oct α2R (OA3) agonist, OctR 1 (OA1) agonist | [ |
| Yohimbine | α2, 5-HT(1B), 5-HT(1D), and D(2) receptor antagonist, 5HT (1A) agonist | TyR 1 antagonist, 5-HT1,2,7 antagonist, OctR1 (OA1) antagonist, TyR>OctR antagonist | [ |
| Prazosin | α1 antagonist | TyR1 (Oct/Tyr) antagonist, 5-HT1,7 antagonist, OctR antagonist | [ |
| Phenylephrine | α1 agonist | TyR agonist, Oct R agonist | [ |
| Clenbuterol | β2 agonist | ND | [ |
| Dobutamine | β1 and α1 agonist | ND | [ |
| Acebutolol | β1 antagonist | ND | [ |
| Sotalol | Non-selective β- blocker | ND | [ |
| Amitriptyline | Noradrenaline and serotonin transport (SERT) inhibitor, 5HT-2A receptor antagonist, TrkA and TrkB receptor agonist | Dop2 antagonist | [ |
| Sch-39166 (Ecopipam) | D1 receptor antagonist | ND | [ |
| SKF-38393 | D1 receptor agonist | Dopamine 1 receptor (Dop1) agonist | [ |
| Domperidone | D2,D3 receptor antagonist | Dop3 (D2 like) antagonist | [ |
| Bromocriptine | D2,D3, 5-HT receptor agonist, α2-adrenergic, D1 receptor antagonist, inactivates dopamine D4 and 5-HT7 receptors | Dop3 (D2 like) agonist | [ |
| Serotonin (5HT) | 5-HT agonist | 5HT1,2,7 agonist, Dop3 (D2 like) agonist | [ |
| 5-Methyl-N,N-dimethyltryptamine (5-MeO-DMT) | 5-HT agonist | 5-HT2 agonist | [ |
| Ketanserin | 5-HT antagonist | 5-HT2 antagonist | [ |
| Citalopram | SERT inhibitor | ND | [ |
ND-not determined.
Figure 3Female fertility after injection of adrenergic and dopamine-related compounds.
(a) Mean ± standard error of the mean (SEM) proportion of females that oviposited (N = 10 per experiment). The Fisher's exact Test was used to determine the Likelihood of oviposition of the PBS control vs. compound from a minimum of 3 experiments, red error bars indicate p<0.05. (b) Mean ± SEM number of eggs per ovipositing female (Mann Whitney test, in red p<0.05), N/A not applicable. (c) Mean ± SEM hatching rate of eggs laid per female (Student's t-test, in red p<0.05).
Figure 4Premature egg melanisation phenotype mediated by tyramine.
(a) Ovary dissection of PBS (control) and tyramine-injected females 3 days post-bloodmeal. (b) Representative examples of eggs dissected from female ovaries ~24 h after aminergic compound injection. (c) Mean ± SEM melanisation ratio of egg batches dissected from ovaries of 31–35 injected females from 3 repeats. (d) Mean ± SEM number of eggs laid by females following injection of tyramine alone or in combination with other compounds (N = 10 per experiment, minimum of 3 experiments, Student's t-test, in red p<0.05). (e) Proportion of females that survived 24 h post-injection with compounds (N = 10, minimum of 3 repeats, Student's t-test, in red p< 0.05). (f) Mean ± SEM melanisation ratio of egg batches laid by injected females (N = 10 per experiment, 3 experiments, Student's t-test, in red p< 0.05).
Figure 5Effect of aminergic compounds on flying ability and survival.
(a) Flying ability of females in response to injection of aminergic compounds at various concentrations after CO2 knockdown (N = 15). Effects were grouped in 3 classes: in green - no effect; in orange- significant effect, but 50% of females recovered within 3 h; in red- significant effect, recovery lower than 50% within 3 h. The experiment was performed in a minimum of 3 independent repeats. Curves were analysed by non-linear regression (one phase association, constraint: plateau level lower than 0.7, extra sum of squares F- test, p<0.05 is significant). ND-not determined (b) Survival rate of 15 females injected with compounds that caused significant effects on flight recovery (N = 15 per experiment, 3 repeats, Student's t-test, p<0.05 is significant).
Figure 6Larval survival in the presence of dissolved tyramine, citalopram and amitriptyline.
(a) In 5 repeats the survival of 10 larvae per treatment (final concentration: 40 mM, 1 mM, 400 uM, 100 uM) was monitored and compared to the PBS control over a period of 24 h. (Student's t-test, p<0.05 is significant). (b) Larval survival rate (N = 10) within 6 h after rearing in 40 mM compound solution.